Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

PSMD14 inhibits IRF3. 2 / 2

| 1 1

➶

eidos

"Deubiquitinase PSMD14 / POH1 prevents IRF3 from autophagic degradation by cleaving the K27-linked poly-ubiquitin chains at lysine 313 on IRF3 to maintain its basal level and IRF3-mediated type I IFN activation ."

32476569

➶

reach

"Deubiquitinase PSMD14 and POH1 prevents IRF3 from autophagic degradation by cleaving the K27 linked poly-ubiquitin chains at lysine 313 on IRF3 to maintain its basal level and IRF3 mediated type I IFN activation."

32476569

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...